Literature DB >> 20473253

Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis.

G Zagli1, M Bonizzoli, R Spina, G Cianchi, A Pasquini, V Anichini, S Matano, F Tarantini, A Di Filippo, E Maggi, A Peris.   

Abstract

AIM: The beneficial role of hemofiltration with immobilized polymyxin-B fiber (PMX) columns in sepsis, especially sepsis due to gram-negative bacteria, has previously been emphasized. Although the efficacy of PMX-B fiber-mediated hemofiltration in reducing plasma levels of cytokines has been reported, other studies did not confirm this observation. Here we report the effects of PMX-B fiber-mediated hemofiltration on outcome and cytokine plasma levels in patients with abdominal sepsis.
METHODS: Twelve consecutive patients admitted to the Intensive Care Unit (October 2006-December 2007) for severe sepsis/septic shock from abdominal infection were treated with standard therapy and 2 cycles of hemofiltration with PMX cartridges. Clinical data and plasma levels of IL-6, IL-10 and TNF-a were measured 24 hours before and after PMX treatment.
RESULTS: Plasma concentrations (pg/mL) of IL-6, IL-10 and TNF-a were significantly lower after hemofiltration with a PMX fiber column (279.9+/-69.2 vs. 130.9+/-18.4, 166.4+/-36.7 vs. 45.5+/-12.2, 83.1+/-13.5 vs. 23.9+/-5.1 pg/mL, respectively; P<0.05). After treatment, patients required lower doses of norepinephrine (0.3+/-0.1 vs. 0.8+/-0.1 mg/kg/min) and reduced lactate levels, recovery of respiratory function and improved Simplified Organ Failure Assessment (SOFA) scores. After 28 days, 6 patients (50%) had survived. Subgroup analysis demonstrated that survivors had higher IL-6 and lower IL-10 and TNF-a pre-treatment plasma levels (pg/mL) compared with deceased patients (324.4+/-41.1 vs.235.3+/-38.4; 98.5+/-16.1 vs. 234.3+/-48.6, 44.5+/-9.0 vs.121.6+/-52.3 pg/mL, respectively; P<0.05). No adverse events imputable to the treatment were recorded.
CONCLUSION: Hemofiltration with a PMX fiber column was able to reduce plasma levels of IL-6, IL-10 and TNF-a, especially in patients surviving at 28 days. Use of the technique was associated with lower norepinephrine support and an increased PaO2/FiO2 ratio.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473253

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  6 in total

1.  Efficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.

Authors:  Jian-ping Gao; Man Huang; Ning Li; Peng-fei Wang; Huan-Lin Chen; Qiu-ping Xu
Journal:  J Zhejiang Univ Sci B       Date:  2011-04       Impact factor: 3.066

Review 2.  Role of cytokines as a double-edged sword in sepsis.

Authors:  Hina Chaudhry; Juhua Zhou; Yin Zhong; Mir Mustafa Ali; Franklin McGuire; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  In Vivo       Date:  2013 Nov-Dec       Impact factor: 2.155

3.  Gas-forming liver abscess associated with rapid hemolysis in a diabetic patient.

Authors:  Miwa Kurasawa; Takashi Nishikido; Junko Koike; Shin-Ichi Tominaga; Hiroyuki Tamemoto
Journal:  World J Diabetes       Date:  2014-04-15

4.  Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.

Authors:  Jin Joo Kim; Young Jun Park; Ki Yoon Moon; Jin Hyeong Park; Yong Ki Jeong; Eun Young Kim
Journal:  World J Gastrointest Surg       Date:  2019-12-27

Review 5.  Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.

Authors:  Elisabeth Esteban; Ricard Ferrer; Laia Alsina; Antonio Artigas
Journal:  Mediators Inflamm       Date:  2013-10-22       Impact factor: 4.711

6.  Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case report.

Authors:  Kazuhito Minami; Yoshihisa Sakaguchi; Daisuke Yoshida; Manabu Yamamoto; Masahiko Ikebe; Masaru Morita; Yasushi Toh
Journal:  Surg Case Rep       Date:  2016-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.